Literature DB >> 11489166

A glycoprotein from Schistosoma mansoni eggs binds non-antigen-specific immunoglobulin E and releases interleukin-4 from human basophils.

K Haisch1, G Schramm, F H Falcone, C Alexander, M Schlaak, H Haas.   

Abstract

We have recently shown that soluble extracts from Schistosoma mansoni eggs (SmEA) triggered basophils from nonsensitized donors to rapidly release interleukin (IL)-4. Assuming that this mechanism might play a role in vivo in biasing the immune response towards a Th2 phenotype, we determined basic properties of the IL-4-inducing activity contained in SmEA. Sensitivity to pepsin digestion indicated protein nature. Binding to and specific elution from Concanavalin A-sepharose suggested that this protein contains mannose residues, thus being a glycoprotein. The IL-4-inducing activity was stable for 30 min at room temperature towards shifting the pH between 3 and 10. When incubated at 100 degrees C, it was stable at pH 3, but less stable at neutral and alkaline pH. Electroelution from an SDS-PAGE gel indicated an apparent molecular weight of the IL-4-inducing activity between 31 and 66 kDa. Although binding to purified human immunoglobulin E (IgE) and activating basophils IgE-dependently, SmEA appears to activate basophils in a non-antigen-specific way, since the cells were purified from noninfected donors. Because the IL-4-inducing activity was found to be released from eggs, it could be an important factor in the environment of the eggs skewing the immune response towards the Th2 phenotype.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11489166     DOI: 10.1046/j.1365-3024.2001.00392.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  6 in total

1.  Interleukin-4-inducing principle from Schistosoma mansoni eggs contains a functional C-terminal nuclear localization signal necessary for nuclear translocation in mammalian cells but not for its uptake.

Authors:  Ishwinder Kaur; Gabriele Schramm; Bart Everts; Thomas Scholzen; Karin B Kindle; Christian Beetz; Cristina Montiel-Duarte; Silke Blindow; Arwyn T Jones; Helmut Haas; Snjezana Stolnik; David M Heery; Franco H Falcone
Journal:  Infect Immun       Date:  2011-01-10       Impact factor: 3.441

Review 2.  Immunological and Biochemical Interplay between Cytokines, Oxidative Stress and Schistosomiasis.

Authors:  Priscilla Masamba; Abidemi Paul Kappo
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

3.  Use of humanised rat basophilic leukaemia cell line RS-ATL8 for the assessment of allergenicity of Schistosoma mansoni proteins.

Authors:  Daniel Wan; Fernanda Ludolf; Daniel G W Alanine; Owen Stretton; Eman Ali Ali; Nafal Al-Barwary; Xiaowei Wang; Michael J Doenhoff; Adriano Mari; Colin M Fitzsimmons; David W Dunne; Ryosuke Nakamura; Guilherme C Oliveira; Marcos J C Alcocer; Franco H Falcone
Journal:  PLoS Negl Trop Dis       Date:  2014-09-25

4.  Antibody responses induced by Trichobilharzia regenti antigens in murine and human hosts exhibiting cercarial dermatitis.

Authors:  L Lichtenbergová; P Kolbeková; P Kourilová; M Kasný; L Mikes; H Haas; G Schramm; P Horák; L Kolárová; A P Mountford
Journal:  Parasite Immunol       Date:  2008 Nov-Dec       Impact factor: 2.280

Review 5.  Characterization of the Schistosoma transcriptome opens up the world of helminth genomics.

Authors:  Karl F Hoffmann; David W Dunne
Journal:  Genome Biol       Date:  2003-12-24       Impact factor: 13.583

6.  Changes in IgE- and antigen-dependent histamine-release in peripheral blood of Schistosoma mansoni-infected Ugandan fishermen after treatment with praziquantel.

Authors:  Mohamed Z Satti; Pierre Cahen; Per S Skov; Sarah Joseph; Frances M Jones; Colin Fitzsimmons; Karl F Hoffmann; Claus Reimert; H Curtis Kariuki; Francis Kazibwe; Joseph K Mwatha; Gachuhi Kimani; Birgitte J Vennervald; John H Ouma; Narcis B Kabatereine; David W Dunne
Journal:  BMC Immunol       Date:  2004-04-21       Impact factor: 3.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.